Regional Nasal Block and Dexmedetomidine in Endoscopic Sinus Surgery
NCT ID: NCT05361642
Last Updated: 2022-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2022-02-03
2022-12-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lidocaine and Dexmedetomidine Infusions for Intraoperative Bleeding in Functional Endoscopic Sinus Surgery
NCT06848764
Dexmedetomidine Different Doses as Adjuvant to Entropy-assisted General Anesthesia During Functional Endoscopy Sinus Surgery.
NCT05226325
The Effect of Intraoperative Infusion of Dexmedetomidine Versus Low Dose Ketamine
NCT05828199
Intranasal vs. IV Dexmedetomidine in Endoscopic Sinus Surgery
NCT05595083
Comparative Study Between the Effect of Dexmedetomidine ,Midazolam or Bupivacaine Packing During FESS on Surgical Field Visualization
NCT07013955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
regional nasal block
sphenopalatine ganglion block with general anesthesia
Bupivacaine HCl 0.5% Injectable Solution
using nasal block including sphenopalatine ganglion block with general anesthesia to optimize surgical field
dexmedetomidine
use the drug with general anesthesia
Dexmedetomidine
using dexmedetomidine with induction of general anesthesia to optimize surgical field
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine HCl 0.5% Injectable Solution
using nasal block including sphenopalatine ganglion block with general anesthesia to optimize surgical field
Dexmedetomidine
using dexmedetomidine with induction of general anesthesia to optimize surgical field
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with age 18-65 years.
Exclusion Criteria
* Known allergic reactions to local anesthetics.
* Patients with history for cerebrovascular or coronary insufficiency.
* Patients with infection at the block site.
* Patients with coagulopathy.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nahed Effat Yossef Salama, Professor
Role: STUDY_CHAIR
Ain Shams University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Moustafa Rakha
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMASU MD 60/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.